Tea tree oil inclusion in OTC antiseptic monograph may require additional studies -- FDA.
This article was originally published in The Tan Sheet
Executive Summary
TEA TREE OIL INCLUSION IN OTC ANTISEPTIC MONOGRAPH will probably require additional clinical studies, FDA staff indicated at a July 24 "OTC feedback" meeting with representatives of Thursday Plantation and the American Tea Tree Association.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning